Evidence map›Paper›PMID 35943003›Full record

Trial reportArchives of Iranian medicine2022

Comparison of Vitamin D, Neurofeedback, and Neurofeedback Combined with Vitamin D Supplementation in Children with Attention-Deficit/Hyperactivity Disorder.

Masoud Rahmani, Azadeh Mahvelati, Amir Hossein Farajinia, Shima Shahyad, Mojtaba Khaksarian, Roghieh Nooripour, Saba Hassanvandi

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Archives of Iranian medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 5 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 5 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Masoud RahmaniSchool of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.
Azadeh MahvelatiDepartment of Counseling, Imam Reza International University, Mashhad, Iran.
Amir Hossein FarajiniaDepartment of Psychology, Faculty of Humanistic Sciences, Khorramabad Branch, Islamic Azad University, Khorram Abad, Iran.
Shima ShahyadNeuroscience Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mojtaba KhaksarianLorestan University of Medical Sciences, Khorramabad, Iran.
Roghieh NooripourDepartment of Counseling, Faculty of Education and Psychology, Alzahra University, Tehran, Iran.
Saba HassanvandiDepartment of Psychology, Faculty of Humanistic Sciences, Khorramabad Branch, Islamic Azad University, Khorram Abad, Iran.ORCID 0000-0002-9920-9781
Islamic Azad University, Khorramabad Branch · IRAlzahra University · IRBaqiyatallah University of Medical Sciences · IRImam Reza International University · IRLorestan University of Medical Sciences · IRUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNowadays, some treatments such as neurofeedback and Vitamin D Supplementation are of great importance in the treatment of attention-deficit/hyperactivity disorder (ADHD). To determine the efficacy of the combined treatment, the present trial was conducted to investigate the effectiveness of each one of them with combined neurofeedback and vitamin D supplementation in the reduction of ADHD symptom in children suffering from this disorder.

methodsIn this study from March 2020 to June 2020, we enrolled a total of 120 patients (6-15 years old) who were referred to the Mehr psychiatric hospital (affiliated to Lorestan University of Medical Sciences). Patients were then randomly categorized into three experimental groups and one control group. The first, the second, and the third experimental groups consumed vitamin D pearl, neurofeedback combined with vitamin D, and neurofeedback for 12 weeks, respectively. The control group was given no treatment. Vitamin D serum level was evaluated at baseline, 4, 8, and 12 weeks in all participants. For data collection, the Parent Attention-Deficit/Hyperactivity Disorder Rating Scale-IV (ADHD-RS-IV) was applied. The obtained information was analyzed using repeated measure variance analysis.

resultsThe mean scores were significantly different across the groups. Repeated measure variance analysis showed that the mean score was lower in the combined group in comparison with the other three groups (

conclusionCombined treatment could be considered as more effective compared to separate treatments. In addition, in this study, by applying the combined intervention, the duration of treatment decreased significantly.

Indexed as

Attention Deficit Disorder with HyperactivityNeurofeedbackAdolescentChildDietary SupplementsHumansTreatment OutcomeVitamin DVitaminsVitamin DVitaminsAttention-deficit/hyperactivity disorderBrain wavesCombined treatmentNeurofeedbackSupplementationVitamin D

Identifiers

PMID35943003
PMCPMC11904292
OpenAlexW4285103272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.